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Background: Infectious diarrhea can be caused by bacteria, viruses, or protozoan organisms, or a combination
of these. The identification of co-infections in dogs is important to determine the prognosis and to plan strategies
for their treatment and prophylaxis. Although many pathogens have been individually detected with real-time
polymerase chain reaction (PCR), a comprehensive panel of agents that cause diarrhea in privately owned dogs
has not yet been established. The objective of this study was to use a real-time PCR diarrhea panel to survey the
frequencies of pathogens and co-infections in owned dogs attended in a veterinary hospital with and without
diarrhea, as well the frequency in different countries. Feces samples were tested for canine distemper virus,
canine coronavirus, canine parvovirus type 2 (CPV-2), Clostridium perfringens alpha toxin (CPA), Cryptosporidium
spp., Giardia spp., and Salmonella spp. using molecular techniques.
Results: In total, 104 diarrheic and 43 control dogs that were presented consecutively at a major private
veterinary hospital were included in the study. Overall, 71/104 (68.3%) dogs with diarrhea were positive for at
least one pathogen: a single infection in 39/71 dogs (54.9%) and co-infections in 32/71 dogs (45.1%), including
21/32 dogs (65.6%) with dual, 5/32 (15.6%) with triple, and 6/32 (18.8%) with quadruple infections. In the control
group, 13/43 (30.2%) dogs were positive, all with single infections only. The most prevalent pathogens in the diarrheic
dogs were CPA (40/104 dogs, 38.5%), CPV-2 (36/104 dogs, 34.6%), and Giardia spp. (14/104 dogs, 13.5%). CPV-2
was the most prevalent pathogen in the dual co-infections, associated with CPA, Cryptosporidium spp., or Giardia
spp. No statistical difference (P = 0.8374) was observed in the duration of diarrhea or the number of deaths (P = 0.5722)
in the presence or absence of single or co-infections.
Conclusions: Diarrheic dogs showed a higher prevalence of pathogen infections than the controls. Whereas
the healthy dogs had only single infections, about half the diarrheic dogs had co-infections. Therefore, multiple
pathogens should be investigated in dogs presenting with diarrhea. The effects of multiple pathogens on the
disease outcomes remain unclear because the rate of death and the duration of diarrhea did not seem to be
affected by these factors.
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Table 2 Virus, bacteria and protozoan association in
diarrheic and control feces of dogs
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Canine infectious diarrhea has been considered a chal-
lenge for veterinarians because of its pathogenic variability
and the concurrent presence of viral, bacterial, and proto-
zoan co-infections [1,2]. Whereas some pathogens remain
on the mucosal surface and produce potent enterotoxins
that can disrupt the fluid flux, others penetrate and repli-
cate within intact epithelial cells, producing inflammatory
damage and/or destroying the host cells, which are over-
lapping pathological processes [3]. However, many dogs
harbor potential pathogens without any clinical signs, so
the cause–effect relationships are far from clear.
Molecular tools have been used for the identification
and diagnosis of infectious diseases, in addition to conven-
tional culture techniques and antibody-based tools [4,5].
Among these molecular approaches, the use of real-time
polymerase chain reaction (PCR) has greatly improved
the sensitivity and sensibility of standard PCR assays of
pathogens in canine fecal samples [6].
Therefore, although a number of pathogens have been
individually detected with real-time PCR, including
Salmonella spp. [6] and pathogenic Escherichia coli strains
[7], a comprehensive panel of potentially diarrhea-causing
pathogens in owned dogs is yet to be established. There-
fore, the aim of this study was to investigate pathogenic
co-infections in populations of diarrheic and control




Potential enteropathogens were identified in 71/104 (68.3%)
diarrheic samples in the present study, most of which
contained multiples pathogens. Single infections were
observed in 39/71 (54.9%) positive samples and co-
infection in 32/71 (45.1%) possible samples. Dual, triple,
and quadruple infections were observed among the co-
infections (Table 1). The most prevalent agent involved
in co-infections was canine parvovirus type 2 (CPV-2),
and 21/36 (58.3%) of the diarrheic samples positive forTable 1 Prevalence of single or co-infection in diarrheic
and control feces using a real-time PCR panel
Dogs P value
Infection Control (43) n (%) Diarrheic (104) n (%)
Negative 30/43 (69.8) 33/104 (31.7) < 0.0002
Positive 13/43 (30.2) 71/104 (68.3) < 0.0002
Single 13/13 (100) 39/71 (54.9) 0.004
Co-infection None 32/71 (45.1) 0.004
Dual None 21/32 (65,6) —————
Triple None 5/32 (15.6) —————
Quadruple None 6/32 (18.8) —————CPV-2 were associated with others agents, most com-
monly with Clostridium perfringens alpha toxin (CPA),
Cryptosporidium spp., and Giardia spp. Although 13/43
(30.2%) of the feces samples from the control dogs were
positive for the panel of diarrhea-causing pathogens, no
co-infection was observed in any of these samples.
Of the 71/104 (68.3%) dogs with diarrhea and positive
results, 26.8%, 28.2%, and 4.2% had pure viral, bacterial,
and protozoan infections, respectively, whereas 7.0%, 14.0%,
and 9.3% of samples from the control dogs were positive
for viral, bacterial, and protozoan infections, respectively.
The association of viral and bacterial infections was the
most prevalent type of co-infection in the diarrheic
group (37.5%), with CPV-2 and canine coronavirus (CCoV)
constituting 75.0% of this type of co-infection. Viral
and protozoan co-infections accounted for 25.0% of these
associations, bacterial and protozoan for 6.2%, and viral,
bacterial, and protozoan co-infections for 21.9% (Table 2).
A significant association was found between dogs with
diarrhea and positive results on the real-time PCR diar-
rhea panel compared with the control dogs with normal
feces (P < 0.001).
The detection of individual pathogens in the panel
with real-time PCR (Table 3) showed that CPA was the
most prevalent pathogen in the fecal samples, infecting
40/104 (38.5%) diarrheic dogs and 6/43 (14.0%) control
dogs, and the difference between the groups was highly
statistically significant (P = 0.006). Despite this, it was
necessary to quantify CPA to consider its probable role.
When the pre-established cutoff of > 300,000 copies/g of
feces was applied [8], a significant difference (P = 0.0025)
between the control group (4/43, 9.3%) and the diarrheic
group (37/104, 35.6%) was observed. CPV-2 was the second
most prevalent pathogen, found in 36/104 (34.6%) diarrheic
dogs and 0/43 (none) control dogs, and also showed a
highly significant difference between the groups (P < 0.001).Dogs Brazil




Viral 0.01306 3/43 (7.0) 19/71 (26.8)
Bacterial 0.10720 6/43 (14.0) 20/71 (28.2)
Protozoan 0.42284 4/43 (9.3) 3/71 (4.2)
Co-infection
Viral and viral None 3/32 (9.4)
Viral and bacterial None 12/32 (37.5)
Viral and protozoan None 8/32 (25.0)
Bacterial and protozoan None 2/32 (6.2)
Viral, bacterial and protozoan None 7/32 (21.9)
Table 3 Individual infectious agents in the real-time PCR canine diarrhea panel of dogs from Southern Brazil
Pathogen




95% CI Pvalue(n = 104) (n = 43)
Overall rate* 71 (68.3) 58.3- 76.9 13 (30.2) 17.67 - 46.3 < 0.001
Canine distemper virus** 9 (8.7) 4.3 - 16.2 0 (0) 0 – 10.2 0.058
Canine parvovirus type 2* 36 (34.6) 25.7 - 44.7 0 (0) 0 – 10.2 0.001
Salmonella spp. 1 (1) 0.05 - 6.01 0 (0) 0 – 10.2 1
Cryptosporidium spp. 8 (7.7) 3.6 - 15.0 2 (4.7) 0.8 - 17.1 0.723
Giardia spp. 14 (13.5) 7.8 - 21.9 2 (4.7) 0.8 - 17.1 0.151
Canine coronavirus 12 (11.5) 6.4 - 19.7 3 (7) 1.8- 20.1 0.554
C. perfringens alpha toxin gene* 40 (38.5) 29.2 – 48.5 6 (14) 5.8 – 28.6 0.006
*Significantly (P < 0.05) different between Diarrhea Group and Control Group.
**Significantly (P < 0.1) different between Diarrhea Group and Control Group.
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canine distemper virus (CDV), the difference between the
diarrheic and control dogs was not significant (P = 0.059).
Similarly, 12/104 (11.5%) diarrheic and 3/43 (7.0%) control
dogs were positive for CCoV, and these rates were not
significantly different (P = 0.554).
Only 1/104 (1.0%) and 8/104 (7.7%) diarrheic dogs were
positive for Salmonella spp. and Cryptosporidium spp.,
respectively. In the control group only 2/43 (4.7%) were
positive for Cryptosporidium spp., and the two groups did
not differ significantly (P = 0.724). Although Giardia spp.
were detected in 14/104 (13.5%) diarrheic dogs and 2/43
(4.7%) control dogs, the difference was not significant
(P = 0.151).
Diarrhea in relation to age
Among the diarrheic samples, 43/104 were from 0–1-
year-old dogs, 36/104 from 1–8-year-old dogs, and 25/
104 from dogs > 8 years old. The PCR results were posi-
tive in 39/43 (90.7%) samples from animals 0–1 years old,
in 20/36 (55.5%) samples from those 1–8 years old, and
12/25 (48.0%) samples from those > 8 years old. A sig-
nificant association was observed between dog age and
the pathogens CPV-2 (P < 0.0001), Giardia spp. (P = 0.01),
and CCoV (P = 0.02), which were most prevalent among
the 0–1-year-old dogs. Although CPV-2 is considered to
be primarily a disease of puppies, it also occurred in 4/36
(11.1%) animals aged 1–8 years and in 3/25 (12.0%) dogs
aged > 8 years. Only 13/36 (36.1%) of the positive animals
for CPV-2 had no history of vaccination, in which 1/4
(25%) and 1/3 (33.3%) were adults with 1-8 years and 8
years respectively. Details of dates and brands of the
vaccines were not obtained. There was a highly significant
association between age and co-infection (P < 0.0001), which
was more prevalent among the 0–1-year-old dogs, of
which 25/43 (58.1%) had co-infections with two or more
pathogens. Co-infection occurred less often in the other
age groups, occurring in 5/36 (13.8%) dogs in the 1–8-year-old group and 3/25 (12%) dogs > 8 years old. A
significantly higher prevalence (P = 0.0026) of viral and
protozoan associations was observed in the 0–1-year-old
diarrheic dogs than in the other age groups. However, no
significant associations between the other co-infections
and age were observed.
Diarrhea duration in relation to number of pathogens
No significant association (P = 0.8374) was observed be-
tween the duration of diarrhea and the presence of single
or co-infections.
Diarrhea in relation to death
The presence of co-infection did not increase the number
of deaths (P = 0.5722) more than the presence of a single
infection.
Diarrhea in relation to clinical suspicion
In this study, even when diarrhea lasted for more than
10 days, an infectious disease was still clinically suspected
(P = 0.6606).
Diarrhea in relation to the use of antibiotics
During the period from sample collection to the generation
of results for the diarrhea panel analysis (approximately five
days), 40/104 (38.5%) dogs received empirical treatment
with combinations of two to four antibiotics. In total, 40/71
(56.34%) diarrheic dogs with positive PCR results were
treated with antibiotics that were, according to the litera-
ture, inappropriate for the pathogens ultimately identified.
Parasitological diagnosis
In total, 20/104 (19.2%) and 3/43 (7.0%) fecal samples
from diarrheic and control dogs, respectively, were posi-
tive on parasitological tests. The most prevalent intestinal
parasites found in the diarrheic samples were protozoa
(Giardia spp. and/or Isospora spp.), which affected 12/104
(11.5%) dogs, and helminths (Ancylostoma sp. and/or
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parasites found in the three positive control samples were
identified as Ancylostoma sp. When all the samples from
diarrheic and control dogs were considered, 22/23 (95.7%)
positive fecal samples and 61/124 (49.2%) negative fecal
samples on parasitological tests were also positive on the
real-time PCR diarrhea panel.
Of the 13/147 (8.8%) samples positive for helminths
(Ancylostoma sp. and/or Toxocara sp.), 12/13 (92.3%) were
also positive on the real-time PCR. Among the 134/147
(91.2%) samples negative for helminths, 71/134 (52.9%)
were positive on the real-time PCR. Dogs positive for
helminths were 1.7 times more likely to be positive on
the real-time PCR diarrhea panel, which indicates a sta-
tistically significant association (P = 0.006) between the
infections detected with real-time PCR and the presence
of helminths.
Of the 16/147 (10.9%) samples shown to be positive
for Giardia spp. with real-time PCR, only five were
positive on the parasitological tests. Considering that
real-time PCR is the gold standard for the detection of
pathogenic agents, the parasitological test showed 31.2%
sensitivity (95% confidence interval, 12.1%–58.5%).
Isospora spp. were found in 7/147 (8.4%) samples with
the parasitological test, and all of these samples were
also positive for the agents detected with real-time
PCR, suggesting that Isospora spp. are usually involved
in co-infections.
Results between countries
The prevalence of diarrheic dogs observed in the Brazilian
samples (68.3%) was similar to that observed in the United
States (54.5%), Australia (58.4%), Canada (52.0%), United
Kingdom (51.7%), and Japan (49.6%), as shown in Table 4.
The rate of co-infection observed in Brazilian diarrheic
dogs (45.1%) was also higher than those in the otherTable 4 Canine diarrhea panel from diarrheic dogs of Brazil, U
Infectious agent Brazil US
Canine distemper virus 8.7% 1.4%***
Salmonella spp. 1.0% 2.2%
Canine parvovirus type 2 34.6% 1.9%***
Cryptosporidium spp. 7.7% 5.4%
Giardia spp. 13.5% 10.5%
Canine coronavirus 11.5% 13.9%
C. perfringens alpha toxin 38.5% 36.2%
Overall infection rate 68.3% 54.5%**
Coinfection rate 45.1% 24.9%***
Samples included n = 104 n = 7829
*Significantly (P < 0.05).
**Significantly (P < 0.01).
***Significantly (P < 0.001).countries tested (Table 4) and a significant difference
was observed between United States (P < 0.0001),
Australia (P = 0.01) and Canada (P = 0.04).
Discussion
A high prevalence (68.3%) of diarrheic dogs, shown to
harbor at least one pathogen by real-time PCR, was
observed in the Brazilian samples, which exceeded those
in the United States (54.5%), Australia (58.4%), Canada
(52.0%), United Kingdom (51.7%), and Japan (49.6%), as
shown in Table 4. The rate of co-infection observed here
in diarrheic dogs (45.1%) was also higher than those in the
other countries tested. Despite the higher prevalence of
enteropathogens and co-infections in Brazil, the rates in
the other countries are also relevant, indicating that infec-
tious diarrhea may be a global phenomenon rather than
a phenomenon specific to a particular country. Because
all dogs with co-infections belonged to the diarrheic group
and co-infections were observed in all age categories, this
study highlights the importance of investigating multi-
pathogen co-infections, especially in dogs aged 0–1 years,
in which the rate of co-infection was 4-fold higher than
in the other age groups.
Many enteric viruses, bacterial pathogens, and parasites
probably contribute to disease both individually and in
combination [9], and together, co-infecting pathogens
may cause more severe diarrhea than infections with
each pathogen alone [10]. The pathogens involved in a
co-infection can interact synergistically, for example via
the host’s immune system, with the presence of one
enhancing the abundance and/or virulence of the other,
resulting in even greater pathogenesis and a greater
contribution to the overall disease burden [11,12]. There-
fore, interspecific pathogen interactions can alter the
pathogen dynamics, host health, and the success of
control strategies [13,14].nited States, Australia Canada, UK and Japan
Australia Canada UK Japan
Prevalence
2.3%** 1.6%*** 2.5%** 1.0%***
4.6% 5.0% 0.0% 3.0%
6.8%*** 8.0%*** 35.1% 9.0%***
4.0% 14.0% 34.7%*** 9.0%
10.8% 14.0% 20.2% 10.0%
5.1%* 11.0% 16.9% 26.0%***
45.6% 46.0% 51.2%* 21.0%***
58.4% 52.0%** 51.7%** 49.6%***
31.3%* 34.0%* 41.9% 35.3%
n = 526 n = 2855 n = 674 n = 486
Gizzi et al. BMC Veterinary Research 2014, 10:23 Page 5 of 8
http://www.biomedcentral.com/1746-6148/10/23In this study, co-infection did not increase the duration
of diarrhea and there was no significant difference in the
number of deaths in animals with or without co-infections.
Because there was no reliable correlation between the
interaction of enteropathogens in co-infections in this
study, the cause–effect relationship between the presence
of an organism and the occurrence of diarrhea is still
unclear. Opportunistic or commensal organisms may
be identified from an imbalance in the intestinal flora
or dysbiosis, and not all the co-infecting agents present
must be treated to produce a good outcome. However,
because all the infectious agents evaluated here have
been described as causing diarrhea in experimental
studies, knowledge of their presence allows treatments
and prevention strategies to be planned. In this study,
even when diarrhea persisted for more than 10 days, the
infectious diseases were still present in the differential
diagnosis. Empirical treatments and the use of several
antibiotics are common in routine veterinary practice and
the use of a panel to detect multiples pathogens prevents
the incorrect or excessive use of antimicrobial drugs,
which could cause resistance. Furthermore, some of
these pathogens are potential zoonotic agents, including
hookworms, Giardia spp., Cryptosporidium spp., and Sal-
monella spp., and the identification of these organisms
can reduce the risk of their transmission to humans and
others animals.
Although this study focused on client-owned dogs, dogs
received in animal shelters are also expected to carry
pathogen co-infections, including zoonotic agents [15].
However, differences have been observed in the prevalence
of each agent, especially in terms of the co-infection rates,
and dogs from shelters with diarrhea showed a higher
prevalence of co-infection (96.0%) [15] than was observed
in this study (45.1%). That heterogeneous dog population
had a higher rate of crowding, and the dogs may have
been immunocompromised for clinical, nutritional, and/or
psychological reasons, exposed to more environmental
pathogens, and sometimes with inadequate health care, so
their high co-infection rate cannot be compared validly
with that of owned dogs in households.
The highest rate of co-infection in this study involved
the association of viral and bacterial agents, in contrast
to the highest co-infection in dogs in the United States,
which was caused by viruses and protozoans. The high-
est co-infection rates were for CPV-2 and CPA, observed
in 9/12 (75.0%) samples from dogs in Brazil, and for
CCoV and Giardia spp., which occurred together in 35.4%
of dogs from the United States. These co-infections
may have clinical effects and may require more-intensive
efforts to ensure the appropriate treatments to eliminate
specific pathogens and to correct electrolyte, acid–base,
and nutritional disturbances, potential sepsis, and other
metabolic consequences [16].The alpha toxin gene is present in all strains of Clos-
tridium perfringens and may be found in asymptomatic
dogs as part of the normal intestinal microflora [17], as
in 14% of the control dogs in the present study. Data
from some studies indicate that conventional PCR that
targets only CPA will almost always be positive and of
virtually no clinical use [17]. However, a recent study
demonstrated that the quantification of CPA may be used
as a diagnostic marker for association of the agent in
patients with diarrhea [8]. Using the same methodology
and cutoff value as a previous study [8], we observed a
significant difference between the control group (4/43,
9.3%) and in the diarrheic group (37/104, 35.6%; P =
0.0025) in the proportion of animals positive for > 300,000
copies of CPA. The higher amount of CPA in the diarrheic
dogs than in the control dogs suggests that the high
concentrations of toxins produced by this organism exert
a pathogenic effect on the gastrointestinal tract. In the
present study, diarrheic dogs co-infected with CPA had
3-fold more copies than those that were infected with only
CPA. We hypothesize that in these cases, C. perfringens
overgrowth in the bacterial flora increases the toxin
expressed, which contributes to the dog’s diarrhea.
All the control dogs were negative for CPV-2, which
was strongly associated with diarrhea (P = 0.000004), with
an overall occurrence of 36/104 (34.6%) in the diarrheic
dogs. The same prevalence (18/51, 34.6%) was observed in
a study also conducted in Brazil but performed only with
puppies up to 6 months old [18] and corroborated with
previous surveys, which reported rates varying from 16%
[19] to 58% [20]. Although CPV-2 has been considered to
be primarily disease of puppies, the present study has
shown the importance of also investigating adult dogs for
CPV-2, since occurred in 11.1% of 1–8 year old dogs and
in 12.0% of dogs older than 8 years. The CPV-2 was most
prevalent agent involved in co-infections in this study, in
which 58.3% of the diarrheic samples positive for CPV-2
were associated with others agents, contrasting with
only 3.8% CPV-2 co-infection observed in the study
with puppies [18]. This variability may be related to the
geographic regions examined, the populations studied,
agents investigated and the diagnostic techniques used
[20]. Although the date of live-modified vaccination was
not the focus of this study, the CPV-2 cutoff value used
was able to differentiate vaccine strains from wild-type
infections. Despite the use of vaccination, the CPV-2
was still spread among the dogs as observed in this study,
in which only 13/36 (36.1%) of the positive animals for
CPV-2 had no history of vaccination. Still remains unclear
whether type-2 vaccines can provide protection against
the new variants of the CPV, but a recent study observed
that the cases of vaccine failure are most likely not associ-
ated to the mutations detected in the sequenced regions
[21]. Thus, further studies should elucidate whether local
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available vaccines and which factors may be associated
with the vaccination efficacy. CPV-2 was the most preva-
lent agent associated with dual co-infections in the present
study, which may be attributable to highly contaminated
environments or low dog immunity [22].
Although the detection rate of CCoV was higher in
the diarrheic dogs (11.54%) than in the control dogs
(6.98%), the lack of a statistically significant difference
in these rates may indicate a secondary role for CCoV
as an intestinal pathogen in dogs. Although the shedding
of CPV-2 seemed to be associated with clinical signs of
gastroenteritis, CCoV was also detected in healthy dogs,
as previously reported [19]. Although CCoV infections are
characterized by high morbidity and low mortality, with
typically mild enteritis in dogs [23,24], 11/12 (91.7%)
diarrheic dogs with CCoV were co-infected with other
enteric pathogens, which may have aggravated their
clinical signs and even caused higher mortality, as re-
ported earlier for CPV-2 [25], canine adenovirus type
1 [26], and CDV [27]. CDV tended to be significantly
higher in the diarrheic dogs than in the control dogs;
although not significant, the P value was very close to
the limit of significance (P = 0.059).
Whereas some enteropathogens, such as Salmonella
spp., Cryptosporidium spp., and Giardia spp., showed
similar prevalences in the various countries tested (Table 4),
CDV and CPV-2 were approximately 4-fold more prevalent
in Brazil, indicating that the higher incidence of viral
diseases may be related to differences in strain patho-
genicity, vaccination status, and environmental factors.
Although the CPV-2 strain and vaccine status/response
may play important roles in viral infection and host im-
munity, further studies are required to fully understand
this specific pattern of CPV-2 infections in Brazil.
Although intestinal parasites contribute to diarrhea,
95.7% of positive and 49.2% negative samples on the
parasitological tests were also positive on the real-time
PCR diarrhea panel, indicating that fecal parasito-
logical tests alone should not be used as a single diag-
nostic tool.
Conclusions
To the best of our knowledge, this is the first real-time
PCR-based analysis of a panel of diarrhea-causing patho-
gens performed in Brazil. Our results indicate that dogs
with diarrhea show a relatively high prevalence of patho-
genic infections, highlighting the importance of inves-
tigating infectious pathogens in dogs with diarrhea.
Whereas asymptomatic dogs had single infections only,
approximately half the diarrheic dogs presented with
co-infections, emphasizing the importance of the simul-
taneous investigation of multiple pathogens in individual
samples. The most prevalent pathogens in diarrheicdogs in Brazil were C. perfringens alpha toxin, CPV-2, and
Giardia spp. Among the dual co-infections observed,
CPV-2 was most commonly associated with C. perfringens
alpha toxin, Cryptosporidium spp., and Giardia spp.
In this study, co-infection did not increase the dur-
ation of diarrhea or increase the risk of death. However,
considering that all the infectious agents examined have
been described as causing diarrhea in experimental stud-
ies, knowledge of their presence should allow us to plan
treatments and prevention strategies. The effects of mul-
tiple pathogens on the disease outcomes remain unclear,
because neither the death rate nor the duration of diarrhea
seemed to be affected by these factors.
Methods
Study population
A total of 147 (104 diarrheic and 43 asymptomatic) dogs
consecutively presented by owners to the largest private
veterinary hospital of Curitiba City, Southern Brazil, were
included in the study for the realization of the real-time
PCR diarrhea panel, parasitological diagnosis and clinical
data collection.
Fresh fecal samples were collected from all 147 Brazilian
dogs, placed in plastic vials, and kept refrigerated at 4°C
until processing. At sampling, the fecal specimens were
scored according to a five-point fecal scoring system for
dogs, as previously described [28]: 1, liquid or watery feces
with no form; 2, very soft, unformed feces; 3, very soft,
moderately formed feces; 4, firm, well-shaped and cylin-
drical feces. Diarrheic dog feces included those with scores
from 1 to 3, whereas the control dogs had no history of
gastrointestinal disorders (vomiting, diarrhea, or anorexia)
and fecal samples with a score of 4.
Additionally, results from 12,370 commercial samples
using the same real-time PCR diarrhea panel performed
in the Brazilian samples were obtained from samples
originated from United States (7829), Australia (526),
Canada (2855), United Kingdom (674) and Japan (486).
The real-time PCR results for samples collected in differ-
ent countries (Table 4) were obtained either by shipping
the samples to the United States for commercial real-
time PCR analysis (samples from Brazil, United States,
Australia, United Kingdom, and Japan) or by allowing
the diagnostic samples to be analyzed with the same
real-time PCR procedure by the same service provider in
the country of origin (Canada). Nucleic acid quantities,
stability, and quality were assessed using internal sample
controls when the samples were shipped to the United
States for real-time PCR analysis.
The study was approved by the Ethics Committee in
Animal Experimentation and Animal Welfare of the
Federal University of Parana Curitiba Campus, Paraná
State, Southern Brazil (protocol number 036/2011).
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The diarrheic dogs were evaluated for the duration of
diarrhea and death in relation to the presence of single
or co-infections. Was also evaluated whether the clinical
suspicion of association with infectious agents was related
to the duration of diarrhea (≤ 10 days, 10 days to 2 months,
and > 2 months) and whether the correct antibiotics were
used (for empirical treatment after sample collection
but before the results were obtained) based on the patho-
gen ultimately detected.
Real-time PCR
Total nucleic acids were extracted with standard protocols
using a commercial platform (Corbett XTractor-Gene,
Qiagen, Valencia, CA, USA). A housekeeping gene (18S
rRNA) was used to determine the amounts of genomic
DNA and cDNA after reverse transcription and to confirm
DNA integrity.
The PCR tests were based on the IDEXX proprietary
RealPCR™ service platform (IDEXX Laboratories, Inc.,
Westbrook, ME, USA). Briefly, conserved nucleotide
regions were selected and two primers and a hydrolysis
probe were designed to hybridize to them, using com-
mercial software (PrimerExpress Version 3.0, Applied
Biosystems, Foster City, CA, USA). An additional two
primers flanking the fragment amplified in the real-time
PCR assay were designed for sequence verification purposes.
Fecal samples were tested by hydrolysis probe-based real-
time PCR assay for a panel of potential enteropathogens,
including CDV (phosphoprotein G, GenBank acccession
number AY649446.1), CCoV (M gene, Type I, AF502583;
typ eII D13096), CPV-2 (VP2, U22139), CPA (alpha toxin,
L43545), Cryptosporidium spp. (ssrRNA, A093489), Giardia
spp. (ssrRNA, DQ836339), and Salmonella spp. (invasion A
gene, EU348366) at a reference laboratory within 5 days
after collection. CPA was quantified using a pre-established
cutoff of > 300,000 copies/g of feces [8]. For CPV-2 a cutoff
value was used to discriminate vaccine strains from wild-
type infections (1.2 million CPV-2 gene equivalents per
gram of stool). Real-time PCR was performed with standard
primer and probe concentrations using a commercially
available mastermix (LC480 ProbesMaster, Roche Applied
Science, Indianapolis, IN, USA) on a commercially available
real-time PCR platform (Roche LightCycler 480).
Analytical and clinical validation
Real-time PCRs were validated analytically and clinically.
For the analytical validation, each assay was required to
meet six validation criteria: amplification efficiency, linear-
ity, intra-run reproducibility, inter-run reproducibility, r2
value, and signal-to-noise ratio of the fluorescent signal
using a specific synthetic positive control. Each assay had
an analytical sensitivity of 10 molecules and an amplifica-
tion efficiency between 95% and 100%. Clinical sampleswere selected based on a reference method for each test
and a correlation study was performed. The analytical
specificity of all real-time PCR tests was confirmed by
resequencing the clinical sample material using additional
primer pairs positioned outside the synthetic positive
control. Diagnostic sensitivity and specificity based on
comparisons with reference testing methods were in the
high 90% for each real-time PCR test. Gold standard
tests included the immunofluorescence antibody assay
for CDV, enzyme-linked immunosorbent assay for CPV-2
and Giardia, and real-time PCR performed at the Univer-
sity of California Davis for CCoV, Cryptosporidium, and
Salmonella.
To validate each PCR panel test result, seven quality
controls were used for each sample tested: 1) PCR posi-
tive controls (quantitative); 2) PCR negative controls; 3)
negative extraction controls (five per 96-well plate); 4)
DNA internal sample control targeting the host 18S
rRNA to quantify the DNA in the submitted diagnostic
sample; 5) RNA internal sample control targeting the
host 18S rRNA to quantify the cDNA in the submitted
diagnostic sample after reverse transcription; 6) control
to monitor environmental contamination; and 7) spike in
the internal positive control to monitor PCR inhibition.
These controls were used to assess the functionality of
the PCR test protocol (1), the absence of contamination
in the reagents (2) and laboratory (5), the absence of
cross-contamination during the extraction process (3), the
quality and integrity of the DNA and RNA as a measure
of sample quality (4 and 5), the RT protocol (5), the ab-
sence of random positive PCR signals within the PCR
laboratory (6), and the absence of PCR inhibitory sub-
stances carried over from the sample matrix (7).
Parasitological diagnosis
A fecal flotation procedure was performed with zinc sul-
fate [29] and saturated sodium chloride [30] flotation solu-
tions, as described previously. The parasitological test
was performed with light microscopy by identifying the
parasite eggs, larvae, cysts, and oocysts, according to their
morphological characteristics [30,31].
Statistical analysis
The results were subjected to statistical analysis with the
χ2 test or Fisher’s exact probability. Differences were
considered significant when P < 0.05. The statistical analysis
was performed at a website for statistical computation
(VassarStats, Vassar College, Poughkeepsie, NY, USA).
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